NCT05236322 (PCG) is a clinical trial of soft tissue laser in Plasma Cell Gingivitis, sponsored by Ain Shams University.

Who is sponsoring NCT05236322?

NCT05236322 is sponsored by Ain Shams University.

What drugs are being tested in NCT05236322?

Interventions in NCT05236322: soft tissue laser.

What condition does NCT05236322 study?

NCT05236322 studies Plasma Cell Gingivitis.

Is NCT05236322 still recruiting?

NCT05236322 is currently completed. Last updated 11 February 2022.

Last reviewed 2022-02-11 · How we verify

NCT05236322: PCG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Management of Plasma Cell Gingivitis by Two Surgical Techniques

Completed Last updated 11 February 2022

What this trial tests

trial testing soft tissue laser in Plasma Cell Gingivitis in 12 participants. Completed in 20 January 2022.

Timeline

1 January 2022

Primary endpoint
10 January 2022

20 January 2022

Quick facts

Lead sponsor	Ain Shams University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	12
Start date	1 January 2022
Primary completion	10 January 2022
Estimated completion	20 January 2022
Sites	1 location across Egypt

Drugs / interventions tested

soft tissue laser

Conditions studied

Plasma Cell Gingivitis — all drugs for Plasma Cell Gingivitis →

Sponsor

Ain Shams University

Who can join

Eligibility, any sex, with Plasma Cell Gingivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two surgical protocols for management of Plasma cell Ginigivitis; either by surgical enblock resection of cold laser resection

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05236322 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 11 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05236322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing